CEMB Centre of Excellence in
Molecular Biology University of the Punjab
Biopharmaceuticals and Proteomics Lab team photo at CEMB

Research at CEMB

Biopharmaceuticals & Proteomics

The lab develops indigenous biosimilar therapeutics, recombinant proteins and PCR enzymes, and is building nanoparticle-based drug delivery systems to improve the anticancer potential of therapeutic proteins.

Laboratory overview

From biological discovery to practical solutions.

Research applies biotechnology to produce biosimilar drugs and recombinant human proteins — from interferons and interleukins to insulin and erythropoietin — alongside PCR enzymes and kits for research use, with a growing focus on exosome, PLGA and chitosan-based nanoparticle drug delivery.

Biosimilar therapeuticsRecombinant proteins & enzymesNanoparticle drug delivery
Biosimilars production pipeline 01
Diagram of the biosimilars and enzymes production pipeline, from construct synthesis and fermentation through downstream purification, pharmacopoeia analysis and product packaging
From construct synthesis and fermentation to purification, quality analysis and product packaging.

Research programme

What the lab works on

The programme spans discovery, laboratory validation and the development of tools and formulations for real-world use.

  1. 01

    Indigenous protein technology

    Development of indigenous technology and products, commercialising proteins and enzymes for research and development.

  2. 02

    Advanced biosimilars

    Production of advanced biosimilar therapeutics such as interferons, filgrastim and erythropoietin.

  3. 03

    Anticancer protein studies

    Investigating the anticancer potential of recombinant human proteins and peptides.

  4. 04

    Nanoparticle delivery systems

    Exploring exosome, PLGA and chitosan-based nanoparticle systems for targeted drug delivery.

Achievements

Notable outcomes

  • Indigenous production of Taq Polymerase, Hot Start Polymerase and PFU Polymerase
  • Indigenous production of reverse transcriptase
  • Indigenous 2X PCR Mix, 2X Hot Start Mix and 2X qRT-PCR Mix kits
  • Recombinant biosimilar Anakinra
  • Recombinant biosimilar Filgrastim and PEG-Filgrastim
  • Recombinant biosimilar Thrombax
  • Recombinant biosimilar Erythropoietin
  • Recombinant biosimilar Interferon alpha 2a and PEG-Interferon alpha 2a
  • Recombinant biosimilar GCSF and Consensus Interferon

Research group

Meet the team

Contact the Director, group lead or a co-investigator directly, or reach a doctoral researcher by email.

Doctoral researchers

  • Dr. Saad Tahir
  • Muhammad Asad Ali
  • Fujimura Nao Akusa
  • Muhammad Akram
  • Zaheer Abbas

Connect with CEMB

Need more information?

Contact the right team